NCT00328588
- Conditions
- Bronchial Neoplasms, Cancer of Lung, Cancer of the Lung, +12 more
- Locations
-
- Chomutov, Czechia
- Novi Jicin, Czechia
- Ostrava, Czechia
- Prague, Czechia
Clinical trial condition
Respiratory Tract Neoplasms
Explore clinical trials studying Respiratory Tract Neoplasms. Study availability and eligibility vary by location and protocol.
8,077 public trials
1,842 recruiting studies
Respiratory Tract Neoplasms trial results
NCT00119470
- Conditions
- Lung Cancer, Lung Diseases, Lung Neoplasms, +5 more
- Locations
-
- University Hospital Ghent Ghent, Belgium
NCT00034346
- Conditions
- Bronchial Neoplasms, Carcinoma, Carcinoma, Bronchogenic, +16 more
- Locations
-
Not specified
Completed
Treatment for Patients With Non-Small Cell Lung Cancer Who Developed Anemia Due to Chemotherapy
NCT00120679
- Conditions
- Anemia, Bronchial Neoplasms, Carcinoma, Bronchogenic, +11 more
- Locations
-
Not specified
NCT00089726
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
- Locations
-
Not specified
NCT00069875
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +7 more
- Locations
-
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Monday-Friday from 9:00 AM to 5:00 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician Birmingham, Alabama, United States
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Monday-Friday from 9:00 AM to 5:00 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician Boston, Massachusetts, United States
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Monday-Friday from 9:00 AM to 5:00 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician Manhasset, New York, United States
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9AM to 5PM Eastern time (UTC/GMT - 5 hours, EST) or speak with your personal physician Durham, North Carolina, United States
NCT00578149
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
- Locations
-
- Massachusetts General Hospital Boston, Massachusetts, United States
- Dana-Farber Cancer Institute Boston, Massachusetts, United States
NCT00333294
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
- Locations
-
- Research Site Clermont-Ferrand, France
- Research Site Grenoble, France
- Research Site Nantes, France
- Research SIte Paris, France
NCT00252798
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
- Locations
-
- Research Site Woolloonabba, Queensland, Australia
- Research Site East Melbourne, Victoria, Australia
Completed
Iressa 2nd Line Phase III Study in Japan
NCT00252707
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
- Locations
-
- Research Site Nagoya, Aichi-ken, Japan
- Research Site Okazaki, Aichi-ken, Japan
- Research Site Hirosaki, Aomori, Japan
- Research Site Kashiwa, Chiba, Japan